<?xml version='1.0' encoding='utf-8'?>
<document id="27385182"><sentence text="Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans." /><sentence text="Drug transporters are present in various tissues and have a significant role in drug absorption, distribution, and elimination" /><sentence text=" The International Transporter Consortium has identified 7 transporters of increasing importance from evidence of clinically significant transporter-mediated drug-drug interactions" /><sentence text=" The transporters are P-glycoprotein, breast cancer resistance protein, organic anion transporting polypeptide (OATP) 1B1, OATP1B3, organic cation transporter 2, organic anion transporters (OAT) 1, and OAT3" /><sentence text=" Decision trees were created based on in vitro experiments to determine whether an in vivo transporter-mediated drug-drug interaction study is needed" /><sentence text=" Phenotyping is a methodology that evaluates real-time in vivo transporter activity, whereby changes in a probe substrate or probe inhibitor reflect alternations in the activity of the specified transporter" /><sentence text=" In vivo probe substrates and/or probe inhibitors have been proposed for each aforementioned transporter" /><sentence text=" In vitro findings and animal models provide the strongest evidence regarding probe specificity" /><sentence text=" However, such findings have not conclusively correlated with human phenotyping studies" /><sentence text=" Furthermore, the extent of contribution from multiple transporters in probe disposition complicates the ability to discern if study findings are the result of a specific transporter and thus provide a recommendation for a preferred probe for a drug transporter" /><sentence text="" /></document>